Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Argus Health
US Department of Justice
Express Scripts
Fuji
QuintilesIMS
McKinsey
Boehringer Ingelheim

Generated: May 24, 2018

DrugPatentWatch Database Preview

LYSTEDA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Lysteda patents expire, and when can generic versions of Lysteda launch?

Lysteda is a drug marketed by Ferring Pharms Inc and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has eight patent family members in two countries.

The generic ingredient in LYSTEDA is tranexamic acid. There are seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Drug patent expirations by year for LYSTEDA
Pharmacology for LYSTEDA
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis
Medical Subject Heading (MeSH) Categories for LYSTEDA
Synonyms for LYSTEDA
(1r,4r)-4-(aminomethyl)cyclohexane-1-carboxylic acid
(trans)-4-(aminomethyl)cyclohexanecarboxylic acid
1197-17-7
1197-18-8
1510-00-5
197T188
1ceb
204139-EP2277867A2
204139-EP2280003A2
21573-60-4
3-14-00-00868 (Beilstein Handbook Reference)
37YD696II6
4-(Aminomethyl)-Cyclohexanecarboxylic Acid
4-(aminomethyl)cyclohexane-1-carboxylic acid
4-(Aminomethyl)cyclohexanecarboxylic acid
4-(Aminomethyl)cyclohexanecarboxylic Acid (cis- and trans- mixture)
4-Aminomethyl-cyclohexanecarboxylic acid
4-aminomethylcyclohexanecarboxylic acid
4-trans-(Aminomethyl)cyclohexanecarboxylic acid #
4alpha-Aminomethyl-1alpha-cyclohexanecarboxylic acid
6T84R30KC1
701-54-2
701-54-2 (cis+trans)
701-54-2 tranexamic acid
A0236
AB00052260
AB00052260_05
AB00052260_06
AB00052260-04
AB0013391
AB1003647
AC-4687
AC1L1KJH
AC1Q50F3
AC1Q546D
AC1Q5U04
Acide tranexamique
Acide tranexamique [INN-French]
Acido tranexamico
Acido tranexamico [INN-Spanish]
Acidum tranexamicum
Acidum tranexamicum [INN-Latin]
ACMC-209a3u
ACMC-20h19o
AJ-26859
AK134863
AK516712
AKOS005171632
AKOS015854573
AKOS024257901
ALBB-006013
AM84352
AMCA
AMCA|||AMCHA|||HAKU|||TAMCHA
AMCHA
Amchafibrin
AMH
Amikapron
Amstat
AN-47328
AN-646
Anvitoff
ANW-17368
BAY 3517
BB 0260034
BBL004469
BC215624
BDBM50428067
BP-12345
BPBio1_000069
BRD-K15014948-001-01-2
BRN 2207452
BS-3867
BSPBio_000061
BSPBio_002837
C-5054
C12535
Carxamin
CAS-1197-18-8
CCG-39692
CHEBI:48669
CHEBI:94518
CHEMBL292500
CHEMBL877
cis-4-(Aminomethyl)-1-cyclohexanecarboxylic Acid
cis-4-(Aminomethyl)cyclohexanecarboxylic acid
cis-4-aminomethyl-1-cyclohexanecarboxylic acid
cis-4-Aminomethylcyclohexane-1-carboxylic acid
cis-AMCHA
cis-Tranexamic Acid
CL 65336
CL-65336
CS-1965
CTK0H8184
CTK3I9745
Cyclo-F
Cyclocapron
Cyclohexanecarboxylic acid, 4-(aminomethyl)-
Cyclohexanecarboxylic acid, 4-(aminomethyl)-, cis-
Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-
Cyclohexanecarboxylicacid, 4-(aminomethyl)-, cis-
Cyklokapron
Cyklokapron (TN)
D01136
D05HXX
DB-074265
DB00302
DivK1c_000655
DSSTox_CID_25350
DSSTox_GSID_45350
DSSTox_RID_80817
DTXSID3045350
DV 79
DV-79
DV79
EINECS 214-818-2
Emorhalt
EN300-91506
Exacyl
F8886-7867
Femstrual
FMOC-(R)-2-aminobutyric acid
Frenolyse
FT-0654339
FT-0675360
FT-0700806
GTPL6573
GYDJEQRTZSCIOI-KNVOCYPGSA-N
GYDJEQRTZSCIOI-LJGSYFOKSA-N
GYDJEQRTZSCIOI-UHFFFAOYSA-N
H967
HAKU
Hexapromin
Hexatron
HMS1568D03
HMS1921F08
HMS2092P03
HMS2095D03
HMS502A17
HTS001347
HY-B0149
I04-0993
I14-15270
IDI1_000655
KABI 2161
KB-271963
KBio1_000655
KBio2_001871
KBio2_004439
KBio2_007007
KBio3_002337
KBioGR_000511
KBioSS_001871
KS-00000IPI
KS-00000NS2
KSC489O4L
LS-56611
LS-56612
LT00159441
Mastop
MCULE-6087008336
MFCD00001466
MFCD00064951
MolPort-001-792-390
MolPort-002-512-008
NCGC00016569-01
NCGC00016569-02
NCGC00016569-03
NCGC00016569-04
NCGC00016569-05
NCGC00016569-06
NCGC00016569-08
NCGC00016569-09
NCGC00094944-01
NCGC00094944-02
NINDS_000655
NSC 291305
NSC-291305
NSC-758176
NSC291305
NSC758176
Oprea1_786414
OR041375
OR176508
OR208045
OR208047
p-(Aminomethyl)cyclohexanecarboxylic acid
Pharmakon1600-01502026
Prestwick_476
Prestwick0_000171
Prestwick1_000171
Prestwick2_000171
Prestwick3_000171
PubChem19810
Q-201848
Q-9390
rel-(1R,4R)-4-(aminomethyl)cyclohexane-1-carboxylic acid
rel-(1r,4r)-4-(Aminomethyl)cyclohexanecarboxylic acid
Retavase
Rikavarin
Rikavarin (TN)
Rikavarin-S
RP 18,429
RP22118
RTX-010404
s1875
SBB006715
SBI-0051705.P002
SC-19036
SC-90830
SCHEMBL16974
SCHEMBL186034
SCHEMBL349408
SCHEMBL6885575
SCHEMBL9885628
SPBio_000689
SPBio_001982
Spectrum_001391
SPECTRUM1502026
Spectrum2_000655
Spectrum3_001189
Spectrum4_000046
Spectrum5_001258
Spiramin
SR-05000001794
SR-05000001794-3
ST50307111
STK503668
STOCK1N-16183
t-AMCHA
Tamcha
Tox21_110500
TR-023271
TRA0027406
Tranesamic acid
Tranex
tranexamate
tranexamic acid
Tranexamic acid (JP15/USAN/INN)
Tranexamic acid (JP17/USAN/INN)
Tranexamic acid (Transamin)
Tranexamic acid [USAN:INN:BAN:JAN]
Tranexamic acid [USAN:USP:INN:BAN:JAN]
Tranexamic acid cis-form
Tranexamic acid, European Pharmacopoeia (EP) Reference Standard
Tranexamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Tranexamic acid, United States Pharmacopeia (USP) Reference Standard
Tranexamicacid
Tranexamsaeure
Tranexan
tranexmic acid
Tranhexamic acid
tranol
trans 4-aminomethylcyclohexanecarboxylic acid
trans 4aminomethylcyclohexanecarboxylic acid
Trans AMCHA
trans-?4-?(Aminomethyl)?cyclohexanecarboxylic acid
trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid
trans-1-Aminomethylcyclohexane-4-carboxylic acid
trans-4 -(aminomethyl)cyclohexanecarboxylic acid
trans-4- (aminomethyl) cyclohexanecarboxylic acid
trans-4-(aminomethyl)- cyclohexane carboxylic acid
trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid
Trans-4-(aminomethyl)-cyclohexane carboxylic acid
trans-4-(aminomethyl)-cyclohexanecarboxylic acid
trans-4-(Aminomethyl)cyclohexane carboxylic acid
trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-carboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid (Tranexamic acid)
trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester
trans-4-(Aminomethyl)cyclohexanecarboxylic acid, 97%
trans-4-(aminomethyl)cyclohexylcarboxylic acid
Trans-4-Aminomethyl cyclohexane carboxylic acid
trans-4-aminomethyl cyclohexanecarboxylic acid
trans-4-aminomethyl-1-cyclohexane carboxylic acid
trans-4-aminomethyl-1-cyclohexanecarboxylic acid
trans-4-aminomethyl-cyclohexanecarboxylic acid
trans-4-aminomethylcyclohexane carboxylic acid
trans-4-Aminomethylcyclohexane-1-carboxylic acid
trans-4-aminomethylcyclohexanecarboxylic acid
Trans-4-aminomethylcyclohexylcarboxylic acid
trans-4(aminomethyl)cyclohexanecarboxylic acid
trans-Amcha
Trans-p-(Aminomethyl)cyclohexanecarboxylic
trans-p-(Aminomethyl)cyclohexanecarboxylic acid
trans-p-Aminomethylcyclohexanecarboxylic acid
trans-Tranexamic acid
trans4-aminomethylcyclohexane-1-carboxylic acid
Transamin
Transamin (TN)
Transamlon
Trasamlon
TS-02090
Ugurol
UNII-37YD696II6
UNII-6T84R30KC1
WLN: L6TJ AVQ D1Z -T
WT319
Z1741970429
zataranax
ZINC100007011
ZINC100071256
ZINC1542907

US Patents and Regulatory Information for LYSTEDA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Paragraph IV (Patent) Challenges for LYSTEDA
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 650 mg ➤ Subscribe 2011-05-24

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
US Department of Justice
Medtronic
Cipla
Citi
Johnson and Johnson
Merck
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.